Position in DTIL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,001
New position
Shares Held
182
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#63
of 78 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Advisory Services Network, LLC holds $24,652,024 across 161 Biotechnology names. DTIL ranks #110 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
51,990 | $4,893,296 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,953 | $3,054,242 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,218 | $2,330,040 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,314 | $2,089,107 | |
| 5 | RPRX |
Royalty Pharma plc
|
33,855 | $1,624,023 | |
| 6 | EXEL |
Exelixis, Inc.
|
29,442 | $1,262,766 | |
| 7 | OCUL |
Ocular Therapeutix, Inc
|
138,897 | $1,176,456 | |
| 8 | WVE |
Wave Life Sciences Ltd.
|
144,950 | $1,050,887 |
All Filings in DTIL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,001 | 182 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||